» Articles » PMID: 16191672

Long-term Effects of MDMA (Ecstasy) on the Human Central Nervous System Revealed by Visual Evoked Potentials

Overview
Journal Addict Biol
Specialty Psychiatry
Date 2005 Sep 30
PMID 16191672
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies indicate long-term cognitive impairment of MDMA (ecstasy) users. In the present study we attempted to establish whether electrophysiological correlates of low-level cognitive processes present a long-term alteration, dependent on the level of use of ecstasy. We addressed this issue by investigating amplitude and latency of VEPs related to a very simple discrimination task involving sustained attention (arousal). Eight heavy-MDMA users, eight moderate-MDMA users and 18 drug-free control subjects were asked to discriminate whether the digit at the centre of the screen was 1 or 2. None of the subjects (except one) had used MDMA in the 6 months previous testing. We measured psychophysical performance and EEG, recorded in Oz and Fz during task execution. The heavy-MDMA users made significantly more errors than the other two groups (p < .05). Moreover, they presented reduced amplitude but not latency of VEPs in both Oz and Fz. The effect in Oz is present in P200 (for heavy users only, p < .05) and in P300 components (for both MDMA groups; heavy users: p < .001, moderate users: p < .0.5). In Fz, the amplitude effect is present in N250 (for heavy users only, p < .05) and in P300 components (for both MDMA groups; heavy users: p < .05, moderate users: p < .05). The three groups do not differ in early components, reflecting low-level processing. These results provide evidence of long-term electrophysiological abnormality displayed by ecstasy users and agree with the suggestion that even typical recreational doses of ecstasy are sufficient to cause long-term altered cortical activity in humans.

Citing Articles

Biomarkers and neuromodulation techniques in substance use disorders.

Habelt B, Arvaneh M, Bernhardt N, Minev I Bioelectron Med. 2020; 6:4.

PMID: 32232112 PMC: 7098236. DOI: 10.1186/s42234-020-0040-0.


ERP evidence suggests executive dysfunction in ecstasy polydrug users.

Roberts C, Fairclough S, Fisk J, Tames F, Montgomery C Psychopharmacology (Berl). 2013; 228(3):375-88.

PMID: 23532375 DOI: 10.1007/s00213-013-3044-6.


Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.

de Sola S, Tarancon T, Pena-Casanova J, Espadaler J, Langohr K, Poudevida S Psychopharmacology (Berl). 2008; 200(3):425-37.

PMID: 18581098 DOI: 10.1007/s00213-008-1217-5.